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ABSTRACT  
   
Nicotine and tobacco use, whether it be through cigarette smoking or other 
devices, creates negative health conditions in pilots. The literature that was reviewed 
pertained to nicotine withdrawal symptoms and their negative impact on pilot 
performance. There have been studies conducted in order to explore how these symptoms 
impact pilot performance using cigarettes as the only nicotine device and does not specify 
the nicotine levels or the frequency of use. This thesis extends this work to examine the 
relationship between the nicotine withdrawal symptoms and the nicotine behaviors of 
pilots. It was hypothesized that the extent of withdrawal symptoms may differ by device 
and by nicotine levels and frequency of use, with higher levels and more frequent use 
being associated with more severe withdrawal symptoms. These behaviors included the 
device they use to take nicotine whether it be cigarettes, vaporizers, e-cigarettes, or 
smokeless tobacco. The behaviors also included exploration of how nicotine levels relate 
to withdrawal symptoms whether the nicotine level is as low as 3mg or high as 36mg. 
The last relationship that was explored was that between the withdrawal symptoms 
presented in pilots and how often they used nicotine, whether it be often as every day or 
less frequent as 1-2 times a year. It was found that there is no statistical relationship 
between nicotine withdrawal symptoms and the nicotine habits such as device used, 
nicotine level used, and frequency of use.   
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Chapter 1 
INTRODUCTION 
Overview of the Problem 
The reasons for nicotine and tobacco use varies. In most cases, the influence of 
these substances on daily performance will not greatly impact people’s lives. The same 
cannot be said for pilots. Pilots work in environments unlike any other and can be 
susceptible to different types of health risks and physiological taxes. Literature was 
reviewed on the negative health effects and withdrawal symptoms of nicotine and 
tobacco use to show how the effects impact pilots. Studies have been conducted on pilots 
to understand the withdrawal symptoms associated with smoking cigarettes. These 
studies did not pertain to the specific involvement of nicotine or differing devices used 
for the ingestion of the substance. Further, the studies never resulted in new regulations, 
only the need for nicotine and tobacco cessation programs.  
Motivation and Background 
 For over 2,000 years, tobacco and nicotine have been present in America. The 
tobacco industry was steadily growing in the 1700s and flourished in the late 1800s when 
mass-produced cigarettes were made possible with the patenting of a machine (Felman, 
2018). There were many signs throughout history pointing to the dangerous properties of 
tobacco and nicotine. Tobacco was introduced as an insecticide in 1763; in 1828, nicotine 
was identified as a poison when isolated from the tobacco plant; in 1890, 26 states had 
banned nicotine sales to minors; in 1964, the Surgeon General created a study linking 
heart disease and lung cancer with smoking; and, in 1994, the U.S. Food and Drug 
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Administration (FDA) officially recognized nicotine as a substance that created drug 
dependency (Felman, 2018). It was not until 2009 when the Supreme Court granted the 
FDA control over nicotine regulations (Felman, 2018).  
The exact number of pilots who smoke is unknown, and, as of now, nicotine users 
can become pilots. Pilots work in areas of reduced atmospheric pressures, making the 
resultant compromised lung functions from smoking less than ideal. Although symptoms 
differ with each person, cigarettes can affect alertness as well as vision and sleep 
habits.  By February 25, 1990, the federal government banned smoking cigarettes on 
airplanes on almost every domestic flight. Ten years later, smoking was banned on both 
international and domestic flights (Sharkey, 2015). According to FAR 135.127, 
passengers and crew members abide by different rules when it comes to smoking aboard 
commuter aircraft, and there are situations in which a pilot is allowed to smoke on the 
flight deck (Cornell Law School, n.d.). Pilots smoking on the flight deck pose safety 
concerns, such as improperly extinguished cigarettes or exposure to secondhand smoke. 
Unfortunately, the walls of the flight deck are not impenetrable and do not keep smoke 
from escaping into the cabin of the aircraft where the passengers reside and cause 
exposure to secondhand smoke. This very issue has been a reality, as illustrated by 
Olympic Airlines Flight 417, where a passenger who was asthmatic and sensitive to 
secondhand smoke was seated too close to the escaping smoke in the aircraft despite 
repeated requests to be moved to a different seat (Justia US Supreme Court, 2004). This 
passenger ended up dying due to his pre-existing medical condition being aggravated 
from exposure to the cabin environment.  
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Nicotine and tobacco use are part of the leading cause of preventable 
cancer. There are an estimated 12.7 million tobacco users in the world, with about 5.4 
million related deaths each year. The central cause of addiction among tobacco users is 
nicotine (Mishra et al., 2015). In 2010, the Surgeon General concluded nicotine to be just 
as addictive as cocaine or heroin. Many studies have found nicotine to negatively affect 
organs as well as systems in the human body, including cardiovascular, respiratory, renal, 
and reproductive (Mishra et al., 2015). It can also affect insulin resistance and cause 
predisposition to metabolic syndromes and diabetes, which illustrates the negative effects 
of nicotine across many body processes. According to Mishra et.al (2015), due to 
nicotine’s negative effects, such as increased risk of cardiovascular, respiratory, and 
gestational disorders, the sale and distribution of nicotine should be under the supervision 
of trained medical professionals.  
Nicotine has negative withdrawal effects. The FAA officially banned smoking on 
all aircraft in “scheduled passenger interstate, intrastate and foreign air transportation” in 
2000 (Goldner, 2000). Therefore, pilots who are flying long-distance flights often are not 
able to smoke cigarettes, use electronic cigarettes, or use smokeless tobacco. According 
to the FAA, tension, irritability, trouble concentrating, decreased heart rate, lower blood 
pressure, and impaired performance are some of the most significant effects from 
nicotine withdrawal (n.d.). These withdrawal symptoms could contribute to poor pilot 
performance and could result in a lapse in safety. When a pilot is tense or irritable, they 
likely will not be focusing on flying. Trouble concentrating inhibits the pilots’ ability to 
perform their duties in the cockpit. In addition, other disturbances can occur, such as 
decreased heart rate and lower blood pressure, which can cause a pilot to become dizzy or 
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lightheaded, causing slower performance and lack of attention to tasks at hand (Mayo 
Clinic Staff, 2018a). 
Even without the direct negative effects of nicotine, there are also the negative 
withdrawal effects. Pilots who are flying long-distance flights often are not able to smoke 
or use an electronic cigarette or use smokeless tobacco. These withdrawal symptoms 
could attribute to poor pilot performance and result in a lapse in safety. Withdrawal 
symptoms do not only occur for nicotine users who are trying to stop the habit; nicotine 
withdrawal symptoms can occur between 4 and 24 hours after a person smoked their last 
cigarette (McLaughlin, Dani, Biasi, 2015). Two hours after the last cigarette, the body 
has often removed half of the nicotine (Fagerstrom, 2014). Nicotine withdrawal or 
nicotine dependence is fast-acting and can occur in those who continuously exploit 
nicotine. 
Past studies have created a gap in knowledge. The studies examined took place in 
1983 and 2003, both of which only focused on the withdrawal effects of cigarettes rather 
than nicotine as a whole. The studies have simply created a need for additional 
information to be unearthed. At that time, in 1983, there was not a lot of research done on 
the negative effects of smoking cigarettes. Cigarettes were also the main focus for 
negative health impacts. There were no studies conducted for pilots based solely on 
nicotine versus cigarette smoking alone. This parameter did not change in 2003, as the 
primary factor remained to be cigarette smoking. Nicotine withdrawal effects should be 
investigated using various nicotine and tobacco devices, subjective symptoms, and 
frequency of use.  
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There is a wide collection of data that focuses on the negative effects of smoking 
on the health of the human body. The data that was referred to focused on the health 
effects of nicotine, withdrawal symptoms of nicotine, the dangers of the physiological 
effects of smoking withdrawal, and experimental studies of the impact of smoking 
withdrawal on pilot performance. There was a need to conduct additional research on 
other methods besides cigarette smoking withdrawal. There needed to be more emphasis 
on other means of nicotine intake and whether the chosen device and the amount can 
change the withdrawal effects. There was also a lack of information regarding various 
levels of nicotine and their relationship with withdrawal symptoms. The data collected 
should indicate whether nicotine withdrawal symptoms remain constant throughout 
multiple devices, whether frequency of nicotine use changes withdrawal symptoms, and 
if nicotine levels effect withdrawal symptoms. It is hypothesized that withdrawal 
symptoms in pilots are present regardless of the type of nicotine intake, frequency, or 
nicotine level. 
 
 
Chapter 2 
LITERATURE REVIEW 
The Framework 
 The main topic of the research is exploring the affect of nicotine behaviors on 
withdrawal symptoms in pilots. The literature that was reviewed provides background for 
the research question. The effects of nicotine and tobacco on the health of pilots was 
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explored. The essential framework for the literature investigated how tobacco and 
nicotine have long-term effects on pilot health and then how withdrawal symptoms can 
have short-term effects on pilot performance. This literature is reviewed in order to 
provide additional information on how tobacco and nicotine can disrupt the body 
processes. Some of these disruptions, although unfavorable in normal circumstances, can 
have truly injurious consequences for pilots in flight. In addition, studies regarding 
nicotine use by pilots have focused primarily on cigarette use. Cigarettes are not the only 
way for nicotine to be consumed, and it is not the only means pilots are using either. It is 
important that the data cover information about nicotine devices being used to understand 
individual effects and how nicotine’s destructive presence remains. The data reviewed 
discusses the specific impact that cigarette smoking can have on pilot health and 
performance. This leads to information about other tobacco and nicotine intake that 
occurs and the individual concerns and effects other devices cause. Next, withdrawal 
symptoms are viewed in order to set a framework for the research conducted. This 
information is used in order to understand the reasons for the reviewed studies and 
programs that were conducted. The studies in the literature provide an example of how 
the negative impact of nicotine and tobacco has initiated other reviews. The studies also 
show that there is a need for additional research in terms of use, withdrawal symptom 
identification, and pilot performance. 
Cigarette Smoking 
The negative effects of nicotine and tobacco have been documented countless 
times throughout history. The FAA has a list of disqualifying medical conditions that 
declare a pilot unfit. Some of the conditions include: bipolar disease, coronary heart 
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disease, diabetes mellitus requiring hypoglycemic medications, heart replacement, heart 
attack, substance abuse, and drug abuse (FAA, 2016, p. 17-2). Listed in the disqualifying 
medical conditions are substance and drug abuse, which begs the question: why nicotine, 
tobacco, and cigarette use are not included in this “condition”. These substances are not 
only hazardous to human health, but they are extremely addictive. Addictive substances 
will become habit-forming and will result in dependency. Substance dependence can lead 
to substance abuse. 
Some noticeable FAA disqualifying medical conditions include coronary heart 
disease, diabetes mellitus, heart replacement, and heart attack. These medical conditions 
stand out because those who smoke cigarettes or abuse tobacco and nicotine are at a great 
risk for these listed health conditions. As far back as 1973, it was documented that 
cigarette smoking is linked to myocardial infarctions or heart attack and can lead to death 
from coronary heart disease (Aronow, 1973). Additionally, smoking nicotine cigarettes, 
regardless of the level, causes increased systolic blood pressure and increases the blood 
oxygen demand. Smoking nicotine decreases the amount of oxygen available for the 
tissues in the heart (Aronow, 1973). 
Smoking cigarettes further increases the negative health risks of nicotine and 
tobacco. Cigarette smoking harms nearly every organ in the human body, increasing the 
risk of cancer, almost anywhere in the body, from the throat, to the bladder. Smoking 
causes about 90% of all lung cancer deaths and 80% of deaths from chronic obstructive 
pulmonary disease (COPD) (CDC, 2018b). A pilot who smokes cigarettes is decreasing 
the amount of oxygen that not only is available for their heart, but for their entire body. A 
pilot requires additional oxygen in order to perform at higher altitudes. In addition, as 
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altitude increases, night vision degrades due to the reduced pressures of oxygen (FAA, 
2016, 17-24). Therefore, a smoker’s night vision will degrade even faster due to having a 
lower starting oxygen saturation level. Pilots often fly at night. If a pilot has degraded 
night vision, it will be more difficult for them to conduct required tasks, recognize traffic, 
and land the aircraft safely.   
Pilots are often in areas of lower pressure where it becomes more difficult for 
oxygen to be supplied throughout the body. If a pilot who smokes is subject to an area of 
low pressure, they are more likely to get carbon monoxide poisoning. Humans need their 
blood to transport oxygen in order to maintain consciousness and proper metabolic 
activity (DeHart, p.93, 1994). Smoking and carbon monoxide (CO) are of interest in 
aviation due to carbon monoxide’s ability to bind 200 times more easily to hemoglobin 
than oxygen (DeHart, p.93, 1994). A smoker could have 7% carboxyhemoglobin on the 
ground, which is equal to a 93% oxygen saturation level (DeHart, p.93, 1994). Thus, a 
smoker at ground level would have the same oxygen saturation level on the ground as a 
non-smoker at 8,000 ft, causing a smoker to decrease their blood oxygen level before 
conducting flight operations (DeHart, p.93, 1994). The more cigarettes a pilot has during 
the day, the more likely they are to get carbon monoxide poisoning. As the duration of 
smoking increases, CO levels in smokers increase (Deveci, Deveci, Açik, Ozan, 2004). 
The longer a pilot smokes, the more likely they are to get carbon monoxide poisoning. 
Carbon monoxide can cause a person to become weak, dizzy, nauseated, confused, and 
lose consciousness (Mayo Clinic Staff, n.d.). In addition, as altitude increases, night 
vision degrades due to the reduced pressures (FAA, 2016, p. 17-24). Therefore, a 
smoker’s night vision will degrade even faster due to having a lower starting oxygen 
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saturation level. A study in 2004 was conducted in order to prove an effective way to 
confirm a patient’s smoking status and/or habits. It was found that the amount of carbon 
monoxide exhaled in smokers versus non-smokers was significantly higher (Deveci, 
Deveci, Açik, Ozan). The study found there was a positive correlation between daily 
cigarette consumption and CO levels as well as between the duration of smoking and CO 
levels (Deveci, Deveci, Açik, Ozan, 2004). 
Pancreatic cancer is a major concern for smokers. The most common type of 
pancreatic cancer is pancreatic ductal adenocarcinoma (PDAC). Less than 5% of those 
diagnosed with PDAC live past 5 years from the date of diagnosis (Pandol, Apte, Wilson, 
Gukovskaya, Edderkaoui, 2012). Tobacco smoking is one of the major risks in 
contracting PDAC, with nearly one-fourth of pancreatic cancer deaths linked to tobacco 
and adults, on average, lose 13-15 years from their life expectancy (Pandol, Apte, 
Wilson, Gukovskaya, Edderkaoui, 2012). There are more than 7,000 chemicals in 
tobacco smoke, 250 of which are harmful, and 60 of those are carcinogens which are 
cancer-causing agents (Pandol, Apte, Wilson, Gukovskaya, Edderkaoui, 2012). Nicotine 
is a harmful and major component found in tobacco, and although it is not carcinogenic 
on its own, when it metabolizes, it has been found to produce other cancer-causing 
agents. When nicotine reaches the lungs during smoking, it absorbs into the bloodstream, 
metabolizes, and can make its way into the pancreas along with the carcinogenic agents 
(Pandol, Apte, Wilson, Gukovskaya, Edderkaoui, 2012).  
Smoking tobacco is very dangerous to cardiovascular health and is a major cause 
of cardiovascular disease. Smoking accounts for about one in four deaths from 
cardiovascular disease (CDC, 2014a). Cardiovascular disease is the leading cause of 
  10 
death in the U.S., amounting to over 800,000 deaths per year. The chance of 
cardiovascular disease increases with the number of cigarettes smoked each day, as well 
as long-term smoking (CDC, 2014a). The chemicals found in cigarette smoke alters the 
blood vessels in the body, causing them to become inflamed or narrowed (CDC, 2014a). 
The negative change in the blood vessels can lead to other cardiovascular conditions. The 
first condition that can occur is atherosclerosis, which can cause arteries to narrow, 
causing plaque to build up, in turn, reducing blood from flowing to different regions in 
the body (CDC, 2014a). Coronary heart disease can also occur due to plaque buildup in 
the arteries, and the chemicals in cigarette smoke can lead to blood thickening and clots 
forming in veins and arteries. These clots can create a blockage, leading to cardiac arrest 
and death (CDC, 2014a). When the blood flow is interrupted in the body, a stroke can 
occur, resulting in a loss of brain function and can cause permanent brain damage. The 
lack of blood flow can also lead to peripheral arterial disease (PAD), where different 
limbs and parts of the body aren’t able to receive the oxygen in the blood to function 
(CDC, 2014a). In some cases, when the limb becomes too deprived, it has to be removed. 
Smoking can cause early damage to the abdominal aorta, which is the main artery that 
brings blood throughout the body. The damages inflicted by cigarette smoke can create a 
weak area in the aorta and lead to an aneurysm (CDC, 2014a). This is a life-threatening 
condition. The majority of deaths caused from aortic aneurysms are smoking related 
(CDC, 2014a).  
Other Types of Tobacco and Nicotine Intake 
 The most common way to consume tobacco and nicotine is through smoking, 
though other methods exist and are gaining popularity. It is often perceived that 
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smokeless tobacco products, such as chewing tobacco, or “dip”, is a safer alternative to 
smoking cigarettes. The risks still remain with the smokeless alternatives and introduce 
new risks independent of smoking tobacco (Mayo Clinic Staff, 2017). The Chewing 
tobacco is the most common smokeless tobacco product and can be chewed, sucked on, 
or sniffed. Nicotine is still present in this product and is absorbed into the body through 
the soft tissue in the mouth (Mayo Clinic Staff, 2017). Therefore, smokeless products still 
harbor tobacco, and although lung cancer isn’t likely, it can lead to an increased chance 
of oral cancer in the mouth, throat, cheek, gums, or lips. Tobacco is still being introduced 
to the body and can cause other issues such as dental disease due to the increased contact 
of tobacco on a person’s teeth and gums (Mayo Clinic Staff, 2017). A less obvious risk 
would be an increased chance of heart disease due to the rise in heart rate and blood 
pressure from smokeless tobacco products. In addition, nicotine is still present as an 
addictive agent in the product and can be just as addictive as cigarettes (Mayo Clinic 
Staff, 2017). The nicotine is still present in the bloodstream, and those who use 
smokeless tobacco products are often exposing themselves to more nicotine throughout a 
day than cigarette users. It has been found that there is more nicotine in dip than in 
cigarettes, and the nicotine can often stay in the bloodstream longer, making it harder to 
quit (“The dangers of dip”, n.d.). The “high levels of dependence” will create negative 
withdrawal symptoms similar to cigarette users (Mayo Clinic Staff, 2017). 
 Electronic cigarettes (E-cigarettes) and vaporizers are still new to the medical 
world, and there has yet to be any official research or knowledge on the health effects of 
these devices. E-cigarettes have become the “most commonly used tobacco product 
among youth” (CDC, 2018a). Evidently, e-cigarettes do not use tobacco combustion, but, 
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rather, nicotine and other components are converted from liquid, found in cartridges, into 
small particles as an aerosol. The aerosol is inhaled by the user. (Callahan-Lyon, 
2014).  These devices appear to be less harmful due to the lack of burned toxins, 
however, there may be links to negative exposures through the aerosol substance 
(Callahan-Lyon, 2014). According to the Centers for Disease Control and Prevention 
(CDC), the substances in an e-cigarette aerosol include nicotine, ultrafine particles 
inhaled deep into the lungs, diacetyl, which is a chemical flavoring known to lead to lung 
disease, volatile organic compounds, cancer-causing chemicals, and even heavy metals 
such as nickel, tin, and lead (2018a).   
The CDC reported that some e-cigarette products that claim to have no nicotine 
have been found to contain nicotine (2018a). Nicotine is “absorbed through the airway, 
skin, mucous membranes, and gastrointestinal tract” (Callahan-Lyon, 2014). Cigarette 
users rarely face cases of nicotine poisoning, but e-cigarette users’ chances increase due 
to the “high-nicotine concentrations” found in the device cartridges (Callahan-Lyon, 
2014). This problem increases with inconsistent product labelling. Studies were 
conducted to test the reliability of the labels, and liquid was purchased from online and 
in-person retail stores. The liquid ranged from 14.8-87.2mg/mL of nicotine, and the 
measure concentration differed by 50% from the labeled concentration (Callahan-Lyon, 
2014). Despite various studies on the nicotine content inside e-cigarettes, there is still 
inconclusive data about the overall effects.  
Withdrawal Symptoms and Effects 
Nicotine can cause temporary euphoric physiological and psychological 
sensations. The feelings encourage the user to continue ingesting tobacco and/or nicotine. 
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When the substance is continuously used, it results in dependency (Mayo Clinic Staff, 
2018b). The most common withdrawal symptoms are nicotine cravings, anger or 
irritability, anxiety, depression, and weight gain. Other symptoms that have been reported 
include nausea, headaches, coughing, sore throat, trouble sleeping, difficulty 
concentrating, and depressed mood (Burke & Gotter, 2018).  About half of smokers 
experience at least four withdrawal symptoms when they try to quit (National Cancer 
Institute, 2010). 
According to the National Institute on Drug Abuse, nicotine withdrawal 
symptoms are evoked due to the addictive nature of nicotine (2018). When nicotine is 
used a brief surge of endorphins is emitted in the brain and increases levels of dopamine 
which reinforces the nicotine behavior. When nicotine is repeatedly used, the user’s 
dopamine sensitivity is altered, which effects learning, stress, and self-control (NIDA, 
2018). Dependence is when the body becomes used to nicotine being in the system, 
causing withdrawal when nicotine is taken away. According to NIDA, symptoms can 
occur such as “irritability, craving, depression, anxiety, cognitive and attention deficits, 
sleep disturbances, and increased appetite” (2018). These symptoms can occur within a 
few hours, which leads to continued use of the tobacco or nicotine. Withdrawal 
symptoms can continue for a few weeks or even months (NIDA, 2018). Nicotine levels 
peak within 10 seconds and can temporarily boost cognitive functions. However, the 
long-term effects are “associated with cognitive decline” and those in withdrawal have 
diminished attention spans or memory (NIDA, 2018).  Therefore, the pleasurable effects 
of nicotine can only be sustained with continued use and can have negative short-term as 
well as long-term effects. 
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Nicotine and Tobacco Induced Illnesses 
In 2018, a study was conducted on the association between smoking and hypoxic 
conditions with inflammatory and autoimmune diseases. The study showed significant 
evidence that hypoxic conditions can result in altered immune system activity (Hussain, 
Tripathi, 2018). The altered immune system activity occurred in the form of increased 
cellular components of the immune response. This response can result in auto-
inflammatory and auto-antibody generation. It was found that hypoxia and smoking, 
when combined, pose a strong environmental risk factor for inflammatory and 
autoimmune diseases (Hussain, Tripathi, 2018). 
         In 2014, the Surgeon General found that smoking can be a direct cause of type 2 
diabetes. Smokers have a 30-40% greater chance of developing diabetes than non-
smokers (CDC, 2014b). The risk of developing type 2 diabetes increases with the total 
number of cigarettes smoked per day. Smoking has been found to increase inflammation, 
oxidative stress, and is associated with a higher risk of abdominal fat (CDC, 2014b). Both 
inflammation and oxidative stress interferes or causes damage to the body’s cells, and 
belly fat encourages the production of the hormone cortisol, which increases blood sugar. 
It has also been found that the exposure to nicotine reduces the effectiveness of the 
hormone insulin, which helps lower blood sugar levels (CDC, 2014b). The inability to 
use insulin in the body can lead to diabetes. 
            In 2015, a study was conducted by researchers from Harvard T.H. Chan School of 
Public Health, Huazhong University of Science and Technology in China, and National 
University of Singapore regarding the exposure to smoking and secondhand smoke, 
which can lead to increased risk for type 2 diabetes (Fischer, 2015).  The researchers 
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conducted an analysis of 88 previous studies with data from over 6 million participants. 
They found that more than 27 million cases of type 2 diabetes may be credited to active 
smoking (Fischer, 2015). Those who were former smokers had an increased chance of 
contracting type 2 diabetes by 14 percent, while those exposed to secondhand smoke had 
an increased chance of 22 percent (Fischer, 2015). Not only are smokers more at risk of 
contracting diabetes than non-smokers, but the risk of diabetes increases with the number 
of cigarettes smoked per day. Former smokers would be those who used to smoke and no 
longer smoke, light smokers would suggest an estimated 0-19 cigarettes per day, while 
heavy smokers were considered 20 or more cigarettes per day (National Center for 
Chronic Disease Prevention, 2014). The relative risk of contracting diabetes increases 
with the number of cigarettes smoked. 
 Increased insulin resistance can occur in those who smoke, whether they have 
diabetes or not (Gunton, Davies, Wilmshurst, Fulcher, & McElduff, 2002). Smoking also 
has negative effects on those who already have diabetes, leading to increased chances of 
diabetic incidence, aggravation of glucose homeostasis, and chronic diabetic 
complications (Chang, 2012). Smoking leads to conditions that make a person more 
prone to diabetes as well as further aggravate symptoms in those with a diabetic 
condition. Considering diabetes can be a disqualifying medical condition, the FAA 
should want to reduce the chances of a pilot contracting the disease. 
Previous Studies and Cessation Programs 
 The U.S. Military strives to discontinue the use of tobacco and nicotine through 
the use of cessation programs. In 2002, the United States Air Force (USAF) sent out a 
medical command for tobacco use in the Air Force. This was a health promotion to 
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establish procedures for tobacco use in Air Force buildings, facilities, vehicles, and 
aircraft (Carlton, 2002). The policies were established. There were new commanders to 
enforce policies, medical care providers to ask about tobacco use during each encounter, 
and medical treatment facility commanders to provide “tobacco product cessation 
classes” to active-duty members, family members, and retirees. This was all done for the 
goal to create a tobacco-free environment within the Air Force (Carlton, 2002). Despite 
the USAF’s procedures and new installments, the use of smokeless tobacco in the USAF 
exceeded that of civilian use. In 2016, it was found that 16% of USAF Airmen had used 
smokeless tobacco products and 10% regularly used smokeless tobacco (Linde et al., 
2016). 
     In 1983, the FAA authorized research on the effects of smoking withdrawal on 
complex performance and physiological responses. This stemmed from the 1976 petition 
introduced to the FAA to prohibit all smoking on the flight deck during all commercial 
operations and to ban smoking by the commercial flight crew within an 8-hour time 
period before flight operations (Mertens, McKenzie, & Higgins, 1983). At the time, 
scientific evaluations found that the adverse effects of smokers’ health, carbon monoxide 
levels, and nicotine levels of smokers did not have a significant effect on flight 
performance for healthy pilots. Other studies that focused on withdrawal symptoms 
concluded that these symptoms, which included depression, irritability, difficulty 
concentrating, decreased heart rate, falls in blood pressure, and changes in brain activity, 
presented the need for additional research on its effects at cabin altitude (Mertens, 
McKenzie, & Higgins, 1983). The experimentation was conducted at a cabin altitude of 
6,500 feet, and it was found that complex performance was adversely affected by 
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smoking withdrawal. It was also found that when subjects were able to smoke, they were 
able to maintain their level of performance over a 4-hour testing period (Mertens, 
McKenzie, & Higgins, 1983). When the subjects were barred from smoking, their 
performance worsened over the testing period. It was found that the pilots had trouble 
tracking and noticing red lights in the cockpit. These factors were considered 
insignificant until other studies were conducted on tracking performance. The 
participants also had reduced alertness. A significant degradation of performance was 
found, creating concerns that cigarette withdrawal can create safety risks. (Mertens, 
McKenzie, & Higgins, 1983).  
The study stated, “the present findings add to the body of evidence demonstrating 
important adverse effects of short-term smoking withdrawal on performance at a 
simulated operational air carrier altitude” (Mertens, McKenzie, & Higgins, 1983). 
Despite this study, the FAA still believed that smoking should not be banned from the 
flight deck, nor did it provide any recommendations to prevent performance degradation 
due to withdrawal effects. The FAA, rather, recommended that smoking-cessation 
programs were the better choice (Mertens, McKenzie, & Higgins, 1983). Despite findings 
that smoking withdrawal adversely affected performance in the aircraft, there were no 
further recommendations. Thus, it was concluded by this study that smoking caused 
adverse withdrawal symptoms, but it was never directly associated to nicotine or any 
device other than cigarettes (Mertens, McKenzie, & Higgins, 1983). 
In 2003, another study was conducted to research the effects of nicotine 
withdrawal on pilots during flight. This study was conducted using only male aviators, 
who were regular smokers, and who were pilots of military fixed-wing and rotary-wing 
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aircraft (Giannakoulas, Katramados, Melas, Diamantopoulos, & Chimonas, 2003). This 
was another study that was based solely on the exclusivity of cigarette smoking. These 
pilots were given a 12-hour abstention from smoking while performing flight duties 
(Giannakoulas, Katramados, Melas, Diamantopoulos, & Chimonas, 2003). The study 
concluded that short-term withdrawal of nicotine “may be detrimental to flight safety” 
and “may influence flying parameters” (Giannakoulas, Katramados, Melas, 
Diamantopoulos, & Chimonas, 2003). This study provides applicable information to the 
research question, but it does not provide information on additional nicotine uses, 
devices, or frequency. 
Summary and Hypotheses 
The data that has been collected over time regarding tobacco and nicotine use 
have created a necessity for pilot-involved studies. Pilots have a unique environment in 
which they work, therefore, the effects that have been identified can jeopardize flight 
operations. It is shown through the literature that the negative health effects of nicotine 
and tobacco have been thoroughly studied, including the implications on pilots. The 
studies conducted have not proven to be enough to achieve an agreement or regulation for 
nicotine use in pilots and have not explored the effects of nicotine habits on withdrawal 
symptoms. The literature explores the negative effects of nicotine on pilots and its effect 
on pilot performance. Central to these effects are nicotine withdrawal symptoms which 
can pose challenges specific to pilots who are often at work for extended periods without 
nicotine. There is a lack of research on the behaviors of pilots using nicotine and how 
these behaviors are associated with their withdrawal symptoms whether it be the way 
they intake nicotine, how often they use nicotine, or the level of nicotine. 
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This investigation was accomplished through a survey, designed and conducted to 
measure withdrawal symptoms of nicotine users and the relation between these 
symptoms and various nicotine use behaviors. Specifically, the survey that was created 
examined the type of nicotine intake, the frequency of nicotine use, and the respondent’s 
normal nicotine level. The information produced findings applicable to the impact of 
nicotine habits in pilots and withdrawal symptoms. The research was conducted to 
expand on the general knowledge of nicotine effects on pilots. 
The survey was intended for any pilot who uses nicotine regardless of the vehicle 
in which they intake nicotine or how often. Nicotine devices and frequency of use were 
an important component to the research because they provided an additional layer of 
information in how nicotine can affect an individual’s withdrawal symptoms. Studies that 
have been conducted in the past used the same nicotine device, and the same testing 
period or nicotine abstention time. This study allows another dimension to view nicotine 
effects from different uses and applications. This information could be used to understand 
how, and if, withdrawal symptoms increase under certain circumstances. It can also 
inform whether future nicotine regulations should have specific parameters set, as 
opposed to an overall ban. It is hypothesized that nicotine withdrawal symptoms reported 
will depend on the nicotine implement used, nicotine levels, and frequency of nicotine 
use.  
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Chapter 3 
METHODOLOGY 
Participants 
Forty pilots who self-reported nicotine use and who were 18 years of age or older 
responded to this survey. The survey was distributed anonymously using various contacts 
who were able to send out the survey to an unknown number of pilot respondents. The 
age of the participants varied from 18 years old, to over 75 years old, with half of the 
participants between the ranges of 18-24 years old.  
Survey 
Appendix A includes a copy of the survey questions as presented to the 
participants. The survey was designed to collect information about the participants’ 
general nicotine habits and the effects they feel when those habits cannot be maintained. 
The participants were able to answer as many or as few questions as they deemed 
necessary, as none were required for them to submit the survey. The first two questions 
regarding whether the participant was a pilot and whether they used nicotine were 
included to restrict the sample to pilots who used nicotine. 
The participants were asked to provide information on their specific nicotine 
devices. This was included to provide insight on whether the device used had some 
impact on withdrawal symptoms. Another question that served to find the relation 
between withdrawal symptoms and behavior, asked for the participant’s level of nicotine 
in their device. Another question was designed to find the relationship between 
withdrawal symptoms and the frequency of use by asking the participants how often they 
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used their nicotine device. The participants were also asked to provide the nicotine levels 
they used in their devices. There were several questions given on the 5-point Likert scale 
regarding common withdrawal symptoms and if the participants were often afflicted with 
the presented symptoms and to what degree. The symptoms include difficulty 
concentrating, nicotine cravings, trouble sleeping, hunger, sluggish/tired, irritable/angry, 
headache, nausea, and anxiety/restlessness. The scale was included for these symptoms in 
order to assess how much a pilot is affected by their symptoms.  
Participants were also asked the degree to which their symptoms affected them as 
a whole. The question presented the statement that the participant had no discernible 
symptoms. This question allows the participants to ascertain whether the symptoms are 
detrimental to their daily activities. The participants were asked whether they believed 
their withdrawal symptoms inhibited their daily performance to further evaluate the 
participants’ individual effects and opinions. These questions were designed to provide 
insight into whether the symptoms are benign or if they can cause a more concerning 
lapse in safety. A viewpoint question was included in the survey which was the opinion 
of whether nicotine should be regulated, giving insight to pilots’ views of nicotine 
regulation.  
 
 
 
 
 
 
  22 
Chapter 4 
RESULTS 
The common nicotine withdrawal symptoms were explored alongside the 
frequency of nicotine use, devices used, and nicotine levels presented. It was important to 
understand if the device used to intake nicotine, the level of their nicotine, or how often 
they use nicotine was related to the substance’s negative withdrawal effects. Pilots have 
different views about what affects their own performance and whether a risk is 
acceptable. The entire survey is based on pilots who use nicotine and can identify their 
own symptoms. The main focus for the survey was understanding if pilots’ withdrawal 
symptoms differed with nicotine intake behavior.  
 The devices that were being used by the participants ranged from cigarettes 
(n=11), vaporizers (n=13), e-cigarettes (n=13), smokeless tobacco (n=13), Juul, which is 
another type of e-cigarette, (n=2), and cigar, with seldom use, (n=1), as shown in Figure 
1. Several of the respondents used multiple nicotine devices. This was an interesting 
piece of data to see how some participants will use multiple devices habitually, and a 
large portion of respondents used some type of e-cigarette or vaporizer. According to 
Figure 2, the participants were relatively younger in age and there was an even 
distribution of nicotine devices between e-cigarettes, smokeless tobacco, and cigarettes. 
The participants who smoked cigarettes ranged from less than 1 per day, to 15-20 
cigarettes smoked each day, illustrated in Figure 3. The number of cigarettes smoked per 
day can also point to the amount of nicotine intake by the participants. Figure 4 illustrates 
the level of nicotine that e-cigarette, vaporizer, and Juul users consumed. The majority of 
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the participants used 36mg/mL or 6mg/mL. Most vaporizer and e-cigarette users used 
1mL-5mL of their nicotine liquid per day on average, as shown in in Figure 5.   
 
 
Figure 1. Number of participants by nicotine devices used (N=40)  
 
 
 
Figure 2. Percent of respondents by age (N=40) 
 
0 2 4 6 8 10 12 14
Cigar
Juul
Smokeless tobacco
E-cigarettes
Vaporizers
Cigarettes
Number of Particiapnts
N
ic
o
ti
n
e 
D
ev
ic
es
 U
se
d
  24 
 
  
Figure 3. Percent of respondents by number of cigarettes smoked per day on average 
(N=11) 
  
 
Figure 4. Percent of respondents by amount of nicotine in e-cigarette liquid or cartridge 
(N=21) 
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Figure 5. Percent of respondents by amount of nicotine liquid used by vaporizer and e-
cigarette users (N=22) 
 
 
 
The participants were then asked how often they use their devices. Out of 40 
participants, 37 responded to this question. About 70% of the participants said they used 
their nicotine device every day, as illustrated in Figure 6. From these responses, it is 
inferred that most of the subjects had habits formed with the use of nicotine. Other 
responses ranged from 1-2 times a week, once a week, every month, every few months, 
to 1-2 times a year. Therefore, not all the participants were daily users of nicotine. 
  
Figure 6. Percent of respondents by frequency of use (N=37) 
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Another question that was asked of the participants was how long they waited on 
average between using their nicotine device. The responses to this question were 
widespread, as illustrated in Figure 7. The most common responses were 30-60 minutes 
and every 2 hours. The other responses ranged from less than 30 minutes, to less than 
every day, which would indicate, once again, that not all participants regularly intake 
nicotine.   
 
 
Figure 7. Percent of respondents by wait time between usage (N=40) 
  
 
 The next section of the survey provided various statements to the participants 
about common withdrawal symptoms. The participants were provided the 5-point Likert 
scale where they were able to strongly disagree, disagree, remain neutral, agree, or 
strongly agree with the statements being made about their own symptoms. There were 
several withdrawal symptoms that were more common than others, whereas some rarely 
affected any of the participants. The first statement referred to trouble concentrating 
when not able to have nicotine at the subject’s preferred time. Figure 8 shows only 5 of 
the participants agreed with this statement, while the other 35 participants either 
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disagreed to some degree or were neutral on the symptom. Therefore, it appears most 
participants are able to remain focused despite temporary abstinence from nicotine.  
 
 
Figure 8. Percent of respondents and difficulty concentrating as a withdrawal symptom 
(N=40) 
 
 
 The next withdrawal symptom that was introduced was nicotine cravings when 
not able to intake nicotine at the preferred time. Approximately half of the participants 
experience nicotine cravings, whereas the other half experience none or were neutral to 
the statement, as shown in Figure 9. These cravings would distract from daily activities. 
The next statement pertained to trouble sleeping when nicotine was not used. Figure 10 
shows that only 2 participants believed that they had trouble sleeping, whereas most of 
the subjects disagreed, with a small portion being neutral. Trouble sleeping does not 
appear to be a common issue amongst the survey participants, overall removing the risk 
of lack of sleep from the argument. The next statement referred to hunger felt without 
nicotine. Over half of the participants did not feel hunger due to nicotine withdrawal, 
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illustrated in Figure 11. About a quarter of the participants agreed with the statement that 
hunger was a factor from nicotine absence. 
 
Figure 9. Percent of respondents and nicotine cravings as a withdrawal symptom (N=40) 
 
 
Figure 10. Percent of respondents and trouble sleeping as a withdrawal symptom (N=39) 
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Figure 11. Percent of respondents and hunger as a withdrawal symptom (N=40) 
 
 
 The next withdrawal symptom that was identified was feeling sluggish or tired 
when unable to have nicotine. Almost 70% of the respondents disagreed with this 
statement, around 20% agreed with the statement, and the remaining were neutral, as 
shown in Figure 12. This type of symptom could result in slower reaction time and less 
concentration. 
 
 
Figure 12. Percent of respondents feeling sluggish and tired as a withdrawal symptom 
(N=40) 
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 Irritability and anger were the next symptoms introduced to the participants. 
Figure 13 shows the responses to this question and how they were overall evenly spaced 
between agreeing, disagreeing, and being neutral on the matter. About 35% of the 
participants believed that they became irritable or angry at time of nicotine deprivation. 
This type of a response may make it harder for crew members to work together and may 
result in resentment in the cockpit. 
 
 
Figure 13.Percent of respondents feeling irritability and anger as a withdrawal symptom 
(N=40) 
 
 
 When participants were given the statement that headaches occur when they did 
not use nicotine at their preferred time, the majority of participants disagreed. Over 20% 
of the participants agreed with the statement that headaches were a common withdrawal 
symptom, illustrated in Figure 14. When participants were presented with the symptoms 
of nausea, over 90% of the participants did not feel nausea as a common withdrawal 
symptom, shown in Figure 15. From this question, nausea is not a major withdrawal 
factor for the participants. 
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Figure 14. Percent of respondents and headaches as a withdrawal symptom (N=40) 
 
Figure 15. Percent of respondents and nausea as a withdrawal symptom (N=40) 
 
 
 Next, participants were presented with anxiety and restlessness as a withdrawal 
symptom. The number of participants who disagreed and agreed with the statement were 
about split in half. There was a small number of participants who were neutral in regard 
to the symptom, illustrated in Figure 16. It would make sense that those who crave 
nicotine would feel a sense of restlessness when unable to use it when desired. This type 
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of a reaction, again, leads to a lack of focus or paying attention to details and can even 
cause fatigue. 
 
 
Figure 16. Percent of respondents with anxiety and restlessness as a withdrawal symptom 
(N=40) 
 
  
 To round out the withdrawal-symptoms statements, the participants were asked if 
they had any discernible withdrawal symptoms. A small portion of participants were 
neutral on this statement, whereas about half of the participants believed there were 
noticeable symptoms. Figure 17 shows that less than 40% believed their symptoms were 
not noticeable. Despite the presence of symptoms, many participants believed that their 
daily performance was not inhibited due to nicotine abstention. This belief may be related 
to the general opinion that nicotine use should not be regulated for pilots illustrated in 
Figure 18. Responses to this question may be biased because many people who partake in 
an activity or habit are not going to want to be policed, nor are they going to want to 
admit to having adverse performance. 
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Figure 17. Percent of respondents reporting no discernible symptoms from nicotine 
withdrawal (N=40) 
 
Figure 18. Percent of respondents and the opinion that nicotine intake should be 
regulated for pilots (N=40) 
 
 
 
When participants were asked if nicotine withdrawal symptoms inhibited their 
daily performance, only about 8% of participants agreed, as shown in Figure 19. The 
majority of participants believe that their withdrawal symptoms do not impede normal 
daily activities. Despite symptoms being present and noticeable, almost every participant 
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disagrees with the fact that pilots’ nicotine use should be regulated. This statement makes 
sense because, subjectively, the participants believe they can overcome any withdrawal 
symptoms that might add risk to flight operations.  
 
 
Figure 19. Percent of respondents and reports of symptoms from nicotine inhibiting daily 
performance (N=40) 
 
 
Withdrawal Symptoms and Nicotine Use 
 It is hypothesized that nicotine withdrawal symptoms are related to a pilot’s 
nicotine intake behaviors, whether it is the device, the frequency, or the level of nicotine. 
The data used in the statistical analysis are based on the numerical value of each answer 
for nicotine withdrawal symptoms in relation to the total number of indicated devices 
using 40 participants’ answers. Each withdrawal symptom answer was given a numeric 
value and the total for all symptoms were summed. The values were as follows: strongly 
disagree=1, disagree=2, neutral=3, agree=4, and strongly agree=5. Using the 9 
withdrawal questions and symptoms values, the participants’ total withdrawal values had 
a potential high score of 45 and low score of 9. Multiple unequal variance t-tests were 
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performed in Excel. Using a 95% significance rate, p values less than 0.05 indicate 
statistical significance.  
 The first tests were performed for each device, comparing withdrawal symptoms 
for users and non-users of that device. For example, withdrawal symptoms of cigarette 
users (N=11) and those who did not use cigarettes (N=28) were compared resulting in 
t(37)= -0.13, SE=1.87, p=0.89 indicating no difference in withdrawal symptoms for 
cigarette users and non-users.  The means and standard deviations are shown in Figure 
20. 
 
 
  
Figure 20. Means and standard deviations of withdrawal symptoms for cigarette users 
and non-cigarette users. Cigarette users’ mean: 19.64, Cigarette users’ standard deviation: 
9.73, Non-cigarette users’ mean: 20.07, Non-cigarette users’ standard deviation: 6.49 
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 The next t-test compared vaporizer users (N=13) to non-vaporizer users (N=26). 
This test resulted in t(37)=0.32, SE=1.66, p=0.75 indicating no difference in withdrawal 
symptoms for vaporizer users and non-users. The means and standard deviations were 
calculated with Figure 21 showing the intersection of the standard deviations.  
 
 
 
 Figure 21.  Means and standard deviations of withdrawal symptoms for vaporizer 
users and non-vaporizer users. Vaporizer users’ mean: 20.46, Vaporizer users’ standard 
deviation: 6.85 Non-vaporizer users’ mean: 19.69, Non-vaporizer users’ standard 
deviation: 7.79 
 
   
 The next t-test compared e-cigarette users (N=15) with non-users (N=24). This 
test resulted in t(37)= -0.80, SE=1.64, p=0.43 indicating no difference in withdrawal 
symptoms for e-cigarette users and non-users. The means and standard deviations were 
calculated with Figure 22 showing the intersection of the standard deviations.  
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Figure 22. Means and standard deviations of withdrawal symptoms for e-cigarette users 
and non-e-cigarette users. E-cigarette users’ mean: 18.80, E-cigarette users’ standard 
deviation: 6.36, Non-e-cigarette users’ mean: 20.67, Non-e-cigarette users’ standard 
deviation: 8.05 
 
 Then smokeless tobacco users (N=12)  were tested again non-users (N=27). The 
test resulted in, in t(37)=1.71, SE=1.79, p=0.10 indicating no difference in withdrawal 
symptoms for smokeless tobacco users and non-users. The means and standard deviations 
were calculated with Figure 23 showing the intersection of the standard deviations.  
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Figure 23. Means and standard deviations of withdrawal symptoms for smokeless 
tobacco users and non-users. Smokeless tobacco users’ mean: 23.92, Smokeless tobacco 
users’ standard deviation: 8.18, Non-smokeless tobacco users’ mean: 19.15, Non-
smokeless tobacco users’ standard deviation: 7.62 
 
 
 It was also important to examine if different intakes and frequency of nicotine use 
would affect the overall symptoms. This would indicate whether there is a specific rate of 
nicotine use that creates adverse effects or if symptoms are dependent simply on the 
presence of any nicotine. When considering if frequency of intake changes the 
withdrawal symptoms, we look at what the participants signified as their use. The 
frequency of use was split into two categories with more frequent users being every day, 
1-2 times a week, or once a week. The less frequent users were 1-2 times a year, every 
few months, and every month. These individuals were in the minority. More frequent 
users (N=31)  were tested against non-frequent users (N=5). The test resulted in, in t(34)= 
-0.62, SE=2.16, p=0.56 indicating no difference in withdrawal symptoms for frequent 
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users and non-frequent users. The means and standard deviations were calculated with 
Figure 24 showing the intersection of the standard deviations.  
 
 
 Figure 24. Means and standard deviations of withdrawal symptoms for more 
frequent and less frequent nicotine users. More frequent users’ mean: 18.00, More 
frequent users’ standard deviation: 9.43, Less frequent users’ mean: 20.74, Less frequent 
users’ standard deviation: 7.11 
 
 A majority of the participants were everyday users (N=25) and those who use 
nicotine 1-2 times a week (N=5). These participants were also tested against each other to 
see if these frequencies affected withdrawal symptoms. The test resulted in, t(28)= -0.62, 
SE=2.16, p=0.56 indicating no difference in withdrawal symptoms for frequent users and 
non-frequent users. The means and standard deviations were calculated with Figure 25 
showing the intersection of the standard deviations.  
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 Figure 25. Means and standard deviations of withdrawal symptoms for everyday 
users and 1-2 times a week users. Everyday users’ mean: 21.44, Everyday users’ standard 
deviation: 6.61, 1-2 times a week users’ mean: 18.60, 1-2 times a week users’ standard 
deviation: 9.81 
 
 The additional information that was included was how much nicotine was in a 
participant’s vaporizer or e-cigarette. The nicotine levels that were tested were 3-12mg 
(N=12) and 24-36mg (N=9). Figure 26 shows results of t(19)=0.11, SE=2.14, p=0.92 
indicating no difference in withdrawal symptoms for frequent users and non-frequent 
users. The means and standard deviations were calculated with Figure 18 showing the 
intersection of the standard deviations.  
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Figure 26. Means and standard deviations of withdrawal symptoms for nicotine levels 
between 3-12mg and 24-36mg. 3-12mg mean: 21.33, 3-12mg standard deviation: 6.18, 
24-36mg mean: 21.00, 24-36mg standard deviation: 7.65 
 
 
 
Chapter 5 
DISCUSSION 
Significance of Findings 
 The participants’ responses indicated that there is no significant relationship 
between nicotine withdrawal symptoms and nicotine devices, frequency of nicotine use, 
and level of nicotine used. The results failed to support the hypothesis that the withdrawal 
symptoms change under different nicotine behaviors. There was no evident difference 
between devices and withdrawal symptoms, therefore, it cannot be concluded from this 
study that a specific nicotine device poses additional risks for pilot performance in 
relation to withdrawal. In addition, based on the findings for the frequency of use, there is 
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no apparent difference in nicotine withdrawal symptoms based on how often nicotine is 
used.  The results also showed that the level of nicotine used made little difference in the 
withdrawal symptoms. The findings show that nicotine withdrawal symptoms remain 
relatively similar despite the habits of the nicotine user.  
The withdrawal symptoms that were viewed are subjective, and it is difficult for 
them to be identified by anyone other than the subject experiencing the symptoms. These 
symptoms can affect each person differently, whether they are a pilot or not. It is the 
belief that pilots will be affected by withdrawal differently based on their nicotine habits.  
Thus, a survey was created in order to gather information from pilots who intake nicotine 
and for them to document their honest accounts of nicotine withdrawal and habits. 
Having pilots answer questions about their own symptoms, performance changes, and 
nicotine behaviors is most advantageous because their knowledge is firsthand experience.  
 It was found that approximately 75% (N=40) of the participants believe that their 
nicotine withdrawal symptoms are not detrimental to their daily performance. Although 
the presence of nicotine withdrawal symptoms was not overwhelming, there were 
nonetheless symptoms presented by the respondents. The symptoms, although not 
severely hazardous by themselves, can create distractions during flight that may create 
safety risks. It is difficult to understand the exact impact and risk of withdrawal when 
each person is affected differently, both physiologically and psychologically.  
 The need for the study was supported by the participants’ answers. As 
aforementioned, past studies have had a main focus on the use of cigarettes, however it 
was seen that cigarette users amounted to only about 28% (N=40) of the participants 
surveyed. The other studies were conducted in 2003 and 1983. In 2019, vaporizers and e-
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cigarettes appear to be more prevalent with 70% (N=40) of the participants using one or 
both devices. There are various, popular means of using nicotine today, demonstrating 
the importance of testing the relationship of the behaviors and pilot withdrawal.  
 The survey answers brought to light another matter, where the level of nicotine 
that a person can intake can be drastically different. According to the results the most 
popular nicotine levels in a participant’s vaporizer or e-cigarette were 6mg/mL and 
36mg/mL, counting for approximately 76% (N=21) of respondents that answered. This 
reveals another gap in the literature because nicotine levels have a vast range that are 
available to consumers and had the possibility of effecting withdrawal in pilots.  
 
Limitations 
 The participants themselves potentially differed in many ways. There is the matter 
of information recall, personal experiences, personal biases, and personal minimums. All 
of these are factors that can play a role in the way the participants responded to the 
survey questions. The withdrawal symptoms presented may affect each person 
differently, changing the degree to which they are affected. It appears from the findings 
that many participants who had withdrawal symptoms believed that they could overcome 
the symptoms and their daily performance would not be inhibited. “Daily performance” 
implies normal activities, however, activities that provide additional stress on cognitive 
functions may be affected by nicotine withdrawal symptoms. Additionally, when taking 
part in an activity that a participant believes does not adversely affect them, they will be 
against regulating it. Therefore, the question of whether the participant believed 
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regulation is a good idea relies on their own judgement and view of their own symptoms 
rather than possible real effects.  
Another limitation was that there was a small portion of participants who used 
nicotine rarely or not often. This created outliers in the data, creating a deficiency in 
evidence regarding the difference between those who use nicotine often versus on 
occasion. Another limiting factor for this study is that the participants were not put under 
any situations or conditions in which their actual performance could be tested. There is 
also the matter of what a participant considers nicotine deprivation. One participant may 
be considering the nicotine withdrawal time differently from other participants. This can 
create various views and effects of an individual, depending on the span of time they wait 
and how much nicotine has left their body. Therefore, it is hard to decipher what span of 
time the participant normally must wait before truly feeling nicotine cravings. 
Implications for Future Research 
 This study introduces new ideas regarding different nicotine devices and how they 
can have similar effects on the withdrawal symptoms of an individual. Studies that have 
been conducted in the past have focused on the effects of cigarettes on nicotine 
withdrawal, without considering other devices’ effects. The past studies have also given a 
specific time interval involving nicotine abstention and testing durations. Future studies 
could be improved by testing different nicotine consumptions against each other and 
using varying amounts of time in order to test another component of nicotine withdrawal 
in pilots. It would also be an interesting addition to use participants who have been using 
nicotine for different durations of their life. This may change the way individual’s react 
to withdrawal symptoms. In addition, studies could be done by exposing the participants 
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to varying levels of stress to identify whether withdrawal symptoms are worsened with 
more stressful mental pressures as opposed to normal activities under nicotine 
withdrawal. Simulators could also be used to test pilot performance while under 
withdrawal and when not. These would be best done by comparing both situations in 
which the pilot was not under withdrawal. Therefore, any future research that is 
conducted on this topic should consider all types of nicotine absorption as well as various 
measurements of nicotine. Studies should also include participants whose frequency of 
nicotine use differs. Future studies will be most valuable if they are able to perceive how 
nicotine differences affect pilot performance. Without differing situations, only 
assumptions can be made about what circumstances cause unacceptable nicotine 
withdrawal.     
 
Chapter 6 
CONCLUSION AND RECOMMENDATIONS 
According to the U.S. Drug Enforcement Administration, drugs like heroin are 
illegal due to there being “no recognized medical use and a high potential for abuse” 
(Walker, n.d.). The very same could be said for nicotine, however, it remains legal and 
abused by countless people, including pilots. Tobacco and nicotine use are outdated 
habits, and with today’s medical knowledge, it has been shown that pilots are more 
susceptible to its risks. However, from the results, there was no significant evidence that 
nicotine behavior is related to the extent of withdrawal effects that can potentially impact 
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pilot performance. Nicotine withdrawal effects are common throughout various nicotine 
users despite their habits.  
Nicotine and tobacco are the direct cause of many health conditions that can occur 
in the human body. These conditions lead to a low quality of life, cause other 
disqualifying medical conditions, and can lead to death. One of the FAA’s main duties is 
ensuring the safety of civil aviation through regulation; however, it is improbable for the 
FAA to ban something that is not federally banned. In order for a pilot to earn medical 
certifications, they must be tested by an Aviation Medical Examiner (AME) and be 
approved for a medical certificate (FAA, 2016). These medical certificates include First 
Class, Second Class, and Third Class. First-class certification is normally reserved for 
Airline Transport Pilots who will be flying numerous passengers (FAA, 2016). The 
thought is that if the FAA were to create regulations for nicotine and tobacco, they would 
have to place a contingency, both for the AME, as well as the medical certificate. A pilot 
would need to be tested continuously for tobacco and nicotine in order to prove that they 
remained free of the substances while acting as a pilot. The regulation of nicotine, 
tobacco, and cigarette use in pilots is neglected, but it is not only in the hands of the 
FAA. In order to further ensure the safety of pilots, passengers, crew members, and 
civilians, there needs to be creation and enforcement of policies prohibiting the use of 
nicotine and tobacco by airline pilots in individual companies. 
The research has illustrated that the degree of risk involved with nicotine 
withdrawal is overall constant with various habits. Each person is affected differently by 
physiological conditions as well as different stressful environments. Each pilot is unique 
and will endure different effects from nicotine, as shown in the study. There is no 
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definitive approach to accurately discover which pilots would be able to withstand any 
physiological effects or abnormal flight operations.  
The risk of nicotine may change policy for airline companies and allow them to 
conduct their own research.  Although the safety factor for public companies would 
increase if their pilots were free from tobacco and nicotine, there is also a need to test 
employees. Employees would need to undergo random drug testing to prove the pilot was 
abstaining from the substances. According to OHS Health and Safety Services, individual 
drug screenings can cost between $28-$42 per person. The price often differs depending 
on the number of employees that are tested annually (2004). With this information in 
mind, many airlines already employ a drug testing policy, where the nicotine testing 
would just be an additional substance that is tested for.  
According to Alaska Airlines spokesperson, Marianne Lindsey, Alaska Airlines 
bases their hiring process on whether the candidate smokes or has used tobacco products 
in the last six months (Dubner, 2013). There is also a drug test administered that detects 
nicotine use, meaning that Alaska Airlines would not hire a smoker. The main reason for 
this policy is that smokers are more expensive than non-smokers, estimating to be $4,000 
more expensive for healthcare and productivity loss (Dubner, 2013). However, Alaska is 
one of 21 states that has passed laws allowing for companies to turn down smokers as 
employees, while the other 29 states cannot reject employee candidates based on their 
smoking habits (Dubner, 2013). Alaska Airlines can serve as an example for other 
airlines in their drug policies.  
  The research conducted has provided evidence that differing nicotine habits have 
little difference on the presentation of withdrawal symptoms in pilots. These symptoms 
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are more avoidable with the cessation of tobacco and nicotine, nevertheless, as of now, it 
is still each individual’s choice whether they continue with the habit. Due to the fact 
nicotine withdrawal symptoms were not overwhelmingly present in the participants in the 
study, there is no support for nicotine regulation. However, the literature has shown that 
nicotine has innate risks, but it remains in the hands of companies rather than the federal 
government to police their pilots’ nicotine use. The research has shown that individual 
nicotine behaviors are not related to the extent of nicotine withdrawal on pilots and 
provide no support for regulating the specific nicotine habits of pilots to prevent negative 
effects.  
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Social Behavioral Protocol 
 
Instructions and Notes: 
• Depending on the nature of what you are doing, some sections may not be applicable to your research. If so, 
mark as “NA”.  
• When you write a protocol, keep an electronic copy. You will need a copy if it is necessary to make changes. 
 
1 Protocol Title 
Include the full protocol title: The Implications of Nicotine Withdrawal Symptoms on Pilot Performance 
 
2 Background and Objectives 
Provide the scientific or scholarly background for, rationale for, and significance of the research based on the 
existing literature and how will it add to existing knowledge. 
• Describe the purpose of the study. 
• Describe any relevant preliminary data or case studies. 
• Describe any past studies that are in conjunction to this study. 
The purpose of this study to gain knowledge on general nicotine intake habits, the frequency of nicotine 
use, and withdrawal symptoms for pilots. With this information, it is the hope that the effects of nicotine on 
pilot performance can be better understood. There have been past studies done on pilot withdrawal 
symptoms for only cigarette users over a specified time frame. This study accumulated knowledge on the 
different nicotine devices being used, how often the device is used, and in some cases how much nicotine 
is being taken in. The study differs because it is accumulating more general knowledge rather than based 
off of specific parameters.  
3 Data Use 
Describe how the data will be used.  Examples 
include: 
• Dissertation, Thesis, Undergraduate 
honors project 
• Publication/journal article, 
conferences/presentations 
• Results released to agency or 
organization 
 
 
• Results released to participants/parents 
• Results released to employer or school 
• Other (describe) 
The data will be used in a Master’s Thesis. 
4 Inclusion and Exclusion Criteria 
Describe the criteria that define who will be included or excluded in your final study sample. If you are 
conducting data analysis only describe what is included in the dataset you propose to use. 
Indicate specifically whether you will target or exclude each of the following special populations:  
• Minors (individuals who are under the age of 18) 
• Adults who are unable to consent 
• Pregnant women 
• Prisoners 
• Native Americans 
• Undocumented individuals 
The participants will be adults over the age of 18, capable of giving consent. Those in the study that will be 
used are pilots who intake nicotine.  
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5 Number of Participants 
Indicate the total number of participants to be recruited and enrolled: The goal for the number of people to 
fill out the survey is 30. 
6 Recruitment Methods 
• Describe who will be doing the recruitment of participants. 
• Describe when, where, and how potential participants will be identified and recruited.  
• Describe and attach materials that will be used to recruit participants (attach documents or 
recruitment script with the application). 
The recruitment of participants will be done through known pools of pilots. An email will be sent out 
explaining the survey asking for participants.  
7 Procedures Involved 
Describe all research procedures being performed, who will facilitate the procedures, and when they will be 
performed. Describe procedures including: 
• The duration of time participants will spend in each research activity.  
• The period or span of time for the collection of data, and any long term follow up. 
• Surveys or questionnaires that will be administered (Attach all surveys, interview questions, scripts, 
data collection forms, and instructions for participants to the online application). 
• Interventions and sessions (Attach supplemental materials to the online application).  
• Lab procedures and tests and related instructions to participants.  
• Video or audio recordings of participants. 
• Previously collected data sets that that will be analyzed and identify the data source (Attach data use 
agreement(s) to the online application). 
The research activity is an online survey that will take no more than 5 minutes.  
The period of time for collection has no specific parameters. 
The survey is the primary means of the research. 
There are no interventions or sessions. 
There are no lab procedures. 
There are no audio or video recordings. 
There are no previously collected data sets.  
8 Compensation or Credit 
• Describe the amount and timing of any compensation or credit to participants. 
• Identify the source of the funds to compensate participants   
• Justify that the amount given to participants is reasonable.  
• If participants are receiving course credit for participating in research, 
alternative assignments need to be put in place to avoid coercion.   
There will be no compensation for participating in the survey. 
9 Risk to Participants 
List the reasonably foreseeable risks, discomforts, or inconveniences related to participation in the research. 
Consider physical, psychological, social, legal, and economic risks. 
There are no foreseeable risks to the participants. 
10 Potential Benefits to Participants 
Realistically describe the potential benefits that individual participants may experience from taking part in the 
research. Indicate if there is no direct benefit. Do not include benefits to society or others.  
  56 
There is no direct benefit to the participants by taking part in the survey. 
11 Privacy and Confidentiality 
Describe the steps that will be taken to protect subjects’ privacy interests. “Privacy interest” refers to a person’s 
desire to place limits on with whom they interact or to whom they provide personal information. Click here for 
additional guidance on ASU Data Storage Guidelines. 
Describe the following measures to ensure  the confidentiality of data:  
• Who will have access to the data? 
• Where and how data will be stored (e.g. ASU secure server, ASU cloud storage, filing cabinets, 
etc.)? 
• How long the data will be stored? 
• Describe the steps that will be taken to secure the data during storage, use, and transmission. (e.g., 
training, authorization of access, password protection, encryption, physical controls, certificates of 
confidentiality, and separation of identifiers and data, etc.). 
• If applicable, how will audio or video recordings will be managed and secured. Add the duration of 
time these recordings will be kept. 
• If applicable, how will the consent, assent, and/or parental permission forms be secured. These 
forms should separate from the rest of the study data. Add the duration of time these forms will be 
kept.  
• If applicable, describe how data will be linked or tracked (e.g. masterlist, contact list, reproducible 
participant ID, randomized ID, etc.). 
If your study has previously collected data sets, describe who will be responsible for data security and monitoring. 
The entire survey results will be anonymous and the only ones who have access to the data will be the 
principal investigator and the co-investigator. The results will be stored using the on-line survey tool 
Google Forms.  
12 Consent Process 
Describe the process and procedures process you will use to obtain consent. Include a description of: 
• Who will be responsible for consenting participants? 
• Where will the consent process take place? 
• How will consent be obtained?  
• If participants who do not speak English will be enrolled, describe the process to ensure that the oral 
and/or written information provided to those participants will be in that language. Indicate the 
language that will be used by those obtaining consent.  Translated consent forms should be 
submitted after the English is approved. 
The consent for this anonymous, on-line survey will be in the form of a cover letter.  The consent form was 
modified by removing the signature line and it is stated that filling out the survey will be considered 
consent.  
13 Training 
Provide the date(s) the members of the research team have completed the CITI training for human 
participants. This training must be taken within the last 4 years. Additional information can be found at: 
Training. 
Principal Investigator: Nancy Cooke 
Co-investigator: Halie Bartlowe 
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Survey Consent 
 
The Implications of Nicotine Withdrawal Symptoms on Pilot Performance 
 
I am a graduate student under the direction of Dr. Cooke in the Department of Human 
Systems Engineering at Arizona State University. I am conducting a research study to 
gain knowledge on general nicotine intake habits, the frequency of nicotine use, and 
withdrawal symptoms for pilots. With this information, it is the hope that the effects of 
nicotine on pilot performance can be better understood.  
  
I am inviting your participation, which will involve about 5 minutes of your time, to give 
honest descriptions of your own withdrawal symptoms, nicotine use, and opinion on the 
regulation of nicotine in pilots. You have the right not to answer any question and to stop 
participation at any time. 
 
Your participation in this study is voluntary. If you choose not to participate or to 
withdraw from the study at any time, there will be no penalty. You must be 18 or older to 
participate in the survey.  
 
Although there is no benefit to you, the possible benefits of your participation are to 
better understand pilot performance under nicotine withdrawal and possible creation of 
new policy. There are no foreseeable risks or discomforts to your participation.  
 
Your responses will be anonymous. The results of this study may be used in reports, 
presentations, or publications, but your name will not be used.  
 
If you have any questions concerning the research study, please contact the research 
team: Halie Bartlowe: hbartlow@asu.edu or Nancy Cooke: Nancy.Cooke@asu.edu. If 
you have any questions about your rights as a subject/participant in this research, or if 
you feel you have been placed at risk, you can contact the Chair of the Human Subjects 
Institutional Review Board, through the ASU Office of Research Integrity and 
Assurance, at (480) 965-6788.  
 
By filling out this survey, you are agreeing to be part of this study. 
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Recruitment Email 
Hello, 
 
I am a master’s student at Arizona State University’s Polytechnic Campus seeking a 
degree in Aeronautical Management and Human Factors. I am conducting research for 
my thesis to gain knowledge on general nicotine intake habits, the frequency of nicotine 
use, and withdrawal symptoms for pilots. With this information, it is the hope that the 
effects of nicotine on pilot performance can be better understood.  
 
I am looking for pilots who use nicotine to take part in an anonymous survey that will 
take no longer than 5 minutes. Thank you for your time.  
 
Halie Bartlowe 
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